| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000028164 |
| Receipt No. | R000032238 |
| Official scientific title of the study | A study on objective findings and subjective symptoms in asthenopia after VDT work |
| Date of disclosure of the study information | 2017/07/11 |
| Last modified on | 2018/01/09 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | A study on objective findings and subjective symptoms in asthenopia after VDT work | |
| Title of the study (Brief title) | A study on asthenopia after VDT work | |
| Region |
|
|
| Condition | ||
| Condition | Healthy adult | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To examine the relationship between subjective symptoms and objective findings of asthenopia after VDT work |
| Basic objectives2 | Others |
| Basic objectives -Others | Correlation between the differences of the accommodative microfluctuation (HFC67cm) value and the VAS value in the morning and the evening |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Correlation between the differences of the accommodative microfluctuation (HFC67cm) value and the VAS value in the morning and the evening |
| Key secondary outcomes | 1. Correlation between the differences of the value of HFC1
, HFC2 and the average of HFC value and the VAS value in the morning and the evening 2. Changes of HFC 1, HFC 67 cm, HFC 2, the average of HFC value (HFC parameters) in the morning and evening 3. Presence or absence of background factors affecting changes of HFC parameters in the morning and evening |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | YES |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Measurement of accomdative microfluctuation value by ARK 560 A | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Healty adult and person who agreed to participate in this research | |||
| Key exclusion criteria | 1. A person with myopia exceeding -6 D
2. A person with hyperopia 3. A person who is taking measures against presbyopia (use of reading glasses or bifocal glasses, always removing eyeglasses for VDT work, etc) 4. People who have undergone surgery of LASIK 5. Person who is aware of intense astigmatism 6. Person who is inserting multifocal intraocular lens |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Toshihide Suenobu |
| Organization | Senju Pharmaceutical Co., Ltd |
| Division name | Medical Science Department, Research & Development Division |
| Address | 2-5-8 Hiranomachi, Chuo-ku, Osaka Japan |
| TEL | 06-6201-2552 |
| t-suenobu@senju.co.jp | |
| Public contact | |
| Name of contact person | Futoshi Miyamoto |
| Organization | Senju Pharmaceutical Co., Ltd. |
| Division name | Clinical Resarch Management Group, |
| Address | 2-5-8 Hiranomachi, Chuo-ku, Osaka Japan |
| TEL | 06-6201-2552 |
| Homepage URL | |
| f-miyamoto@senju.co.jp | |
| Sponsor | |
| Institute | Senju Pharmaceutical Co., Ltd.
Clinical Resarch Management Group, |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Senju Pharmaceutical Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 千寿製薬株式会社 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000032238 |